Ocular Therapeutix enrolls first patient in SOL-X extension trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. IBM
6. PRIM
7. SPY
8. ACN
9. NVDA
10. BLZE

Go back to Ocular Therapeutix enrolls first patient in SOL-X extension trial
(NASDAQ: OCUL) Delayed: 10.45 +0.48 (4.81%)
Previous Close $9.97    52 Week High $14.50 
Open $9.83    52 Week Low $4.04 
Day High $10.62    P/E N/A 
Day Low $9.80    EPS $0.00 
Volume 1,697,510